Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research

The Role of Short-Chain Fatty Acids in Myocardial Ischemia-Reperfusion Injury.

  • 2024-08-07
  • Current nutrition reports 13(4)
    • Xunxun Wang
    • Yalan Dong
    • Renyin Huang
    • Fang Wang
    • Junke Xie
    • Hui Liu
    • Yan Wang
    • Yi Wang
    • Shanshan Luo
    • Desheng Hu

Study Design

Type
Review

Purpose of review

This study aims to review the effects of short-chain fatty acids (SCFAs) in regulating the myocardial ischemia-reperfusion injury (MIRI).

Recent findings

Coronary heart disease (CHD) is a well-known leading cause of death and disability worldwide. Cardiac substrate metabolism plays the determinant role in assessing the severity of heart injury due to the abruptly shifted energy production during the MIRI. Fatty acids are the main energy fuels for the heart, which are classified into long-, medium- and short chain fatty acids by the length of carbon chain. SCFAs are the main metabolites derived from the anaerobic bacterial fermentation of fiber-rich diets, which are shown to play a protective role in cerebrovascular disease previously. Meanwhile, accumulating evidences suggest that SCFAs can also play a crucial role in cardiac energy metabolism. Results of various studies revealed the cardioprotective effects of SCFAs by displaying anti-inflammatory and anti-ferroptotic function, connecting gut-brain neural circuit and regulating the intestinal flora.

Research Insights

    Back to top